Printer Friendly

Secura Bio closes USD 145m in financing with funds led by Athyrium Capital.

Global Banking News-March 12, 2019-Secura Bio closes USD 145m in financing with funds led by Athyrium Capital

(C)2019 ENPublishing -

Biopharmaceutical company Secura Bio, Inc. has announced it has closed USD 145 million in equity and debt financing with funds managed by Athyrium Capital Management, LP, a healthcare-focused investment firm, the company said.

The financing was USD 90 million debt financing with USD 50 million initial tranche funded immediately with an additional USD 40 million of funding available.

Secura Bio, Inc. is dedicated to the worldwide commercialization of significant oncology therapies,

Athyrium Capital Management is a specialized asset management company formed in 2008 to focus on investment opportunities in the global healthcare sector. Athyrium advises funds with over USD 3.7 billion in committed capital.

((Distributed via M2 Communications -

COPYRIGHT 2019 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2019 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Global Banking News (GBN)
Date:Mar 12, 2019
Previous Article:Grand Angels launches Woodward Angels as Detroit's 1st angel investment group.
Next Article:Webster Bank offers solution to manage student loan debt.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters